Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm

Experimental and Therapeutic Medicine

Volumn 4, Issue 3, 2012, Pages 514-518

  Oszajca, Katarzyna ^a   Konrad, Wroński ^b   Janiszewska, Grazyna ^a   Małgorzata, Bieńkiewicz ^a   Michał, Panek ^a   Bartkowiak, Jacek ^a   Janusz, Szemraj ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b M Pirogow Regional Specialist Hospital   (Poland)

Author keywords

Abdominal aortic aneurysm; Factor V 1691 G A polymorphism; Factor VII 323 0 10 bp polymorphism; Fibrinogen chain 455 G A polymorphism; Restriction fragment length polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FIBRINOGEN;

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK;

EID: 84863884458     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.608     Document Type: Article

References (43)

1. Hultgren R, Granath F and Swedenborg J: Different disease profiles for women and men with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 33: 556-560, 2007.
2. Michel JB, Martin-Ventura JL, Egido J, et al: Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 90: 18-27, 2011.
3. Sakalihasan N, Limet R and Defawe OD: Abdominal aortic aneurysm. Lancet 365: 1577-1589, 2005.
4. Pajič T: Factor V Leiden and FII 20210 testing in thromboembolic disorders. Clin Chem Lab Med 48 (Suppl 1): 79-87, 2010.
5. Bos MHA and Camire RM: Blood coagulation factors V and VIII: molecular mechanisms of procofactor activation. J Coagul Disord 2: 19-27, 2010.
6. Vos HL: Inherited defects of coagulation factor V: the thrombotic side. J Thromb Haemost 4: 35-40, 2006.
7. Griffin JH, Evatt B, Wideman C and Fernandez JA: Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82: 1989-1993, 1993.
8. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP and Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342: 1503-1506, 1993.
9. Bauer KA: Activation of the factor VII-tissue factor pathway. Thromb Haemost 78: 108-111, 1997.
10. Humphries S, Temple A, Lane A, Green F, Cooper J and Miller G: Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 75: 567-572, 1996.
11. Shimokata K, Kondo T, Ohno M, et al: Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease. Thromb Res 105: 493-498, 2002.
12. Marino MW, Fuller GM and Elder FF: Chromosomal localization of human and rat A alpha, B beta, and gamma fibrinogen genes by in situ hybridization. Cytogenet Cell Genet 42: 36-41, 1986.
13. Lee SH, Kim MK, Park MS, Choi SM, Kim JT, Kim BC and Cho KH: Beta-fibrinogen gene -455 G/A polymorphism in Korean ischemic stroke patients. J Clin Neurol 4: 17-22, 2008.
14. Pongrácz E, Andrikovics H, Csornai M, Bernát IS and Nagy Z: Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients. Clin Hemorheol Microcirc 35: 75-82, 2006.
15. Renner W, Cichocki L, Forjanics A, Köppel H, Gasser R and Pilger E: G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis. Eur J Clin Invest 32: 755-758, 2002.
16. Voetsch B and Loscalzo J: Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24: 216-229, 2004.
17. Lee AJ, Fowkes FG, Lowe GD and Rumley A: Haemostatic factors, atherosclerosis and risk of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 7: 695-701, 1996.
18. Takagi H, Manabe H, Kawai N, Goto S and Umemoto T: Plasma fibrinogen and D-dimer concentrations are associated with the presence of abdominal aortic aneurysm: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 38: 273-277, 2009.
19. Lee AJ, Fowkes FG, Lowe GD, Connor JM and Rumley A: Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis. Edinburgh Artery Study. Thromb Haemost 81: 553-560, 1999.
20. de Maat MP, Kastelein JJ, Jukema JW, et al: -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 18: 265-271, 1998.
21. Martiskainen M, Pohjasvaara T, Mikkelsson J, et al: Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke 34: 886-891, 2003.
22. Bozdemir V, Kirimli O, Akdeniz B, et al: The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation. Anadolu Kardiyol Derg 10: 209-215, 2010.
23. van 't Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P and Hamsten A: Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19: 3063-3070, 1999.
24. Leander K, Wiman B, Hallqvist J, Falk G and De Faire U: The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J Intern Med 252: 332-341, 2002.
25. Iacoviello L, Vischetti M, Zito F and Benedetta Donati M: Genes encoding fibrinogen and cardiovascular risk. Hypertension 38: 1199-1203, 2001.
26. Green D, Foiles N, Chan C, Schreiner PJ and Liu K: Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis 202: 623-331, 2009.
27. Rallidis LS, Gialeraki A, Fountoulaki K, et al: G-455A poly-morphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece. Thromb Res 125: 34-37, 2010.
28. Brown ET and Fuller GM: Detection of a complex that associates with the Bβ fibrinogen G-455- A polymorphism. Blood 92: 3286-3293, 1998.
29. Singh K, Bønaa KH, Jacobsen BK, Bjørk L and Solberg S: Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø Study. Am J Epidemiol 154: 236-244, 2001.
30. Al-Barjas HS, Ariëns R, Grant P and Scott JA: Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 57: 607-614, 2006.
31. Fowkes FG, Anandan CL, Lee AJ, et al: Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. J Vasc Surg 43: 474-480, 2006.
32. Spring S, van der Loo B, Krieger E, Amann-Vesti BR, Rousson V and Koppensteiner R: Decreased wall shear stress in the common carotid artery of patients with peripheral arterial disease or abdominal aortic aneurysm: relation to blood rheology, vascular risk factors, and intima-media thickness. J Vasc Surg 43: 56-63, 2006.
33. Sofi F, Marcucci R, Giusti B, et al: High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm. Thromb Haemost 94: 1094-1098, 2005.
34. Ioannou HV, Mitsis M, Eleftheriou A, et al: The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. Int Angiol 19: 314-318, 2000.
35. Juul K, Tybjaerg-Hansen A, Schnohr P and Nordestgaard BG: Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 140: 330-337, 2004.
36. Sofi F, Lar B, Rogolino A, et al: Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41: 255-260, 2005.
37. Reny JL, Alhenc-Gelas M, Fontana P, et al: The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost 2: 1334-1340, 2004.
38. Renner, W, Köppel H, Brodmann M, et al: Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. Thromb Haemost 83: 20-22, 2000.
39. März W, Seydewitz H, Winkelmann B, Chen M, Nauck M and Witt I: Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 345: 526-527, 1995.
40. Rosendaal FR, Siscovick DS, Schwartz SM, et al: Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89: 2817-2821, 1997.
41. Liu Y, Hengen CK, Saha N, Hong S and Low PS: Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese. Blood Coagul Fibrinolysis 13: 217-224, 2002.
42. Sacchi E, Tagliabue L, Scoglio R, Baroncini C, Coppola R, Bernardi F and Mannucci PM: Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene. Blood Coagul Fibrinolysis 7: 114-117, 1996.
43. Mtiraoui N, Aboud N, Bouraoui H, et al: Reduction in coagulation factor VII plasma levels by R353Q but not the -323P0/10 promoter polymorphism in healthy Tunisians. Am J Hematol 79: 11-16, 2005.